Endotoxin Testing Market Report 2026

Endotoxin Testing Market Overview

• Endotoxin Testing market size has reached to $2.31 billion in 2025 • Expected to grow to $3.12 billion in 2030 at a compound annual growth rate (CAGR) of 6.3% • Growth Driver: The Increase In Healthcare-Associated Infections Fueling The Growth Of The Market Due To Rising Contamination Risks And Strengthened Infection Control Needs • Market Trend: Cutting-Edge Technology Reshapes The Landscape Of Endotoxin Testing Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Endotoxin Testing Market?

Endotoxin testing, or the bacterial endotoxins test (BET), refers to an in vitro assay that involves assessing bacterial endotoxin levels in substances, particularly pharmaceuticals and medical devices, to ensure product safety and compliance with quality standards. This testing helps prevent potential adverse effects on patients and users. The main types of endotoxin testing are LAL (limulus amebocyte lysate) tests, chromogenic tests, turbidimetric tests, gel clot tests, MAT tests, rabbit pyrogen tests and recombinant factor C (rFC) assays. The limulus amebocyte lysate (LAL) test is a highly sensitive assay used to detect the presence of bacterial endotoxins in medical and pharmaceutical products, utilizing the clotting reaction of horseshoe crab blood components. It is used for several applications, including medical devices, pharmaceuticals, packaging and raw materials, by various end-users, including hospitals, laboratories and research institutes.

What Is The Endotoxin Testing Market Growth Forecast?

The endotoxin testing market size is expected to see strong growth in the next few years. It will grow to $3.12 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to biologic drug growth, stricter regulatory audits, automation in quality testing, medical device innovation, contamination risk management. Major trends in the forecast period include rising focus on pharmaceutical safety, increased regulatory compliance requirements, growth in medical device quality testing, expansion of in vitro diagnostic testing, demand for accurate endotoxin detection.

Global Endotoxin Testing Market Segmentation

1) By Test Type: LAL (Limulus Amebocyte Lysate) Test, Chromogenic Tests, Turbidimetric Tests, Gel Clot Tests, MAT Test, Rabbit Pyrogen Test, Recombinant Factor C (rFC) Assay 2) By Application: Medical Devices, Pharmaceuticals, Packaging, Raw Materials 3) By End-User: Hospitals, Laboratories, Research Institutes Subsegments: 1) By LAL (Limulus Amebocyte Lysate) Test: Gel Clot LAL Test, Kinetic LAL Test, Endpoint LAL Test 2) By Chromogenic Tests: Chromogenic LAL Test, Chromogenic Factor C Assay 3) By Turbidimetric Tests: Turbidimetric LAL Test, Turbidimetric Factor C Assay 4) By Gel Clot Tests: Gel Clot LAL Test 5) By MAT Test (Monocyte Activation Test): Direct MAT, Indirect MAT 6) By Rabbit Pyrogen Test: Standard Rabbit Pyrogen Test 7) By Recombinant Factor C (rFC) Assay: RFC Assay For Endotoxin Detection

What Is The Driver Of The Endotoxin Testing Market?

The increasing incidence of healthcare-associated infections (HAIs) is expected to propel the growth of the endotoxin testing market going forward. Healthcare-associated infections refer to infections acquired during medical care that were not present at the time of hospital admission. The rise in HAIs is driven by inadequate infection prevention and control practices, exposure to contaminated medical devices, and the growing prevalence of drug-resistant pathogens. Endotoxin testing enhances patient safety by identifying bacterial endotoxins in medical equipment, injectable pharmaceuticals, and implantable devices, thereby reducing the risk of sepsis, inflammation, and device-related complications. For instance, in November 2024, according to the World Health Organization (WHO), a Switzerland-based public health agency, legally known as the World Health Organization, its Global Report on Infection Prevention and Control 2024 reported that although 71% of countries have active IPC programmes, only 6% met all WHO minimum IPC requirements in 2023–2024, placing millions of patients at heightened risk of HAIs. Therefore, the increasing incidence of healthcare-associated infections is driving the growth of the endotoxin testing industry.

Key Players In The Global Endotoxin Testing Market

Major companies operating in the endotoxin testing market are Thermo Fisher Scientific Inc., Merck KGaA, bioMérieux SA., Eurofins Scientific SE, Lonza Group Ltd., WuXi AppTec Co. Ltd., Bio-Rad Laboratories Inc., Maravai LifeSciences Holdings Inc., Cambrex Corporation, GenScript Biotech Corporation, Charles River Laboratories International Inc., Nelson Laboratories LLC, Lifecore Biomedical Inc., Stellar Biotechnologies Inc., Biovision Inc., Associates of Cape Cod Inc., FUJIFILM Wako Pure Chemical Corporation, InvivoGen Inc., Tebu-bio Nv., MatTek Corporation, Microcoat Biotechnologie GmbH, Accelagen Inc., BioAssay Systems LLC, BioThema AB, Hycult Biotech Inc., Pacific Biolabs Inc., Xiamen Bioendo Technology Co. Ltd., Zhanjiang A&C Biological Ltd., Accugen Laboratories Inc.

Global Endotoxin Testing Market Trends and Insights

Major companies operating in the endotoxin testing market are focusing on developing advanced solutions, such as integrated absorbance microplate readers, to improve testing accuracy, streamline laboratory workflows, and strengthen compliance with data integrity requirements. Advanced absorbance readers in endotoxin testing refer to instruments designed to seamlessly integrate with specialized assay software, support validated workflows, and deliver consistent results aligned with industry standards. For instance, in August 2023, Lonza Group AG, a Switzerland-based pharmaceutical, biotechnology, and nutrition manufacturing company, launched the Nebula Absorbance Reader, a next-generation microplate reader engineered to simplify endotoxin and pyrogen testing. Fully integrated with Lonza’s latest WinKQCL software, the system facilitates data integrity compliance, reduces validation burden, and minimizes training needs by allowing existing WinKQCL users to operate the new reader without learning additional software. Designed as a technologically advanced replacement for the discontinued ELx808 absorbance reader, the Nebula platform delivers comparable performance and is optimized for Lonza’s absorbance-based endotoxin assays, including the PYROGENT 5000 Turbidimetric and Kinetic-QCL Chromogenic Endotoxin Assays.

What Are Latest Mergers And Acquisitions In The Endotoxin Testing Market?

In September 2024, Eurofins Scientific SE, a Luxembourg-based bio-analytical testing organization, acquired Infinity Laboratories Inc. for an undisclosed amount. Through this acquisition, Eurofins aims to strengthen its microbiology and endotoxin testing capabilities by integrating Infinity Laboratories’ network of eight U.S.-based microbiology testing facilities and its team of approximately 100 professionals. Infinity Laboratories Inc. is a US-based company that provider of comprehensive endotoxin testing services.

Regional Outlook

North America was the largest region in the endotoxin testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Endotoxin Testing Market?

The endotoxin testing market consists of revenues earned by entities by providing contract testing services, ecologically sustainable testing and rapid testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The endotoxin testing market also includes sales of injectable pharmaceutical products, endotoxin detection systems, limulus amebocyte lysate test reagents and polymerase chain reaction mycoplasma detection kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Endotoxin Testing Market Report 2026?

The endotoxin testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the endotoxin testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.